Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



White William Richard Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 606 shares @ $55.16, valued at $33.4k
06/12/2023 4 White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 15,937 options to buy @ $34.83, valued at $555.1k
06/09/2023 4 White William Richard (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns: Granted 7,136 options to buy @ $45.69, valued at $326k
03/14/2023 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Paid exercise price by delivering 641 shares @ $43.47, valued at $27.9k
01/24/2023 4 White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Sold 5,048 shares @ $34.3258, valued at $173.3k
Sold 21,278 shares @ $35.0117, valued at $745k
Sold 7,027 shares @ $35.9095, valued at $252.3k
Exercised 33,353 options to buy @ $6.03, valued at $201.1k
01/03/2023 4 White William Richard (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns: Granted 7,000 options to buy @ $13.5, valued at $94.5k
12/29/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 19,001 shares @ $49.7663, valued at $945.6k
Sold 999 shares @ $49.7635, valued at $49.7k
Exercised 19,001 options to buy @ $7.009, valued at $133.2k
Exercised 999 options to buy @ $7.009, valued at $7k
12/20/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 29,073 options to buy @ $21.1, valued at $613.4k
12/13/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 19,195 shares @ $0
Granted 86,379 options to buy @ $42.95, valued at $3.7M
10/17/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 20,000 shares @ $39.82, valued at $796.4k
Exercised 20,000 options to buy @ $7.009, valued at $140.2k
09/15/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 18,920 shares @ $26.42, valued at $499.9k
Sold 13,580 shares @ $27.87, valued at $378.5k
Exercised 32,500 options to buy @ $7.009, valued at $227.8k
09/13/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 1,152 shares @ $8.03, valued at $9.3k
Granted 29,074 options to buy @ $21.1, valued at $613.5k
Granted 29,074 options to buy @ $21.1, valued at $613.5k
06/10/2022 4 White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns: Granted 13,301 options to buy @ $16.54, valued at $220k
01/18/2022 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 9,700 shares @ $22.03, valued at $213.7k
Exercised 9,700 options to buy @ $7.009, valued at $68k
12/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Sold 6,500 shares @ $22.24, valued at $144.6k
Exercised 6,500 options to buy @ $7.009, valued at $45.6k
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2020 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 1,245 shares @ $17.068, valued at $21.2k
Granted 77,580 options to buy @ $28.35, valued at $2.2M
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2019 4 White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.
Txns: Granted 85,000 options to buy @ $21.09, valued at $1.8M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy